ABVC BioPharma, Inc.
ABVC
$1.59
$0.053.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 104.23% | 124.44% | -63.38% | 13.57% | -91.23% |
| Total Receivables | -40.32% | 52.07% | 4.78% | 9.34% | -28.71% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -39.60% | -4.85% | -36.20% | -31.89% | -54.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -3.36% | -6.27% | 1.87% | -3.80% | -4.32% |
| Total Current Assets | -18.11% | 31.57% | -13.84% | 2.86% | -48.44% |
|
|
|||||
| Total Current Assets | -18.11% | 31.57% | -13.84% | 2.86% | -48.44% |
| Net Property, Plant & Equipment | 0.52% | -16.47% | -4.68% | 445.79% | 418.30% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 26.70% | -12.23% | -39.94% | -68.09% | -67.59% |
| Total Assets | 2.87% | -3.14% | -12.83% | 57.01% | 34.70% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -4.13% | 2.76% | -10.61% | -3.95% | 13.15% |
| Short-term Debt | 35.41% | 59.15% | -16.82% | -33.75% | -36.66% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.61% | 3.82% | 280.57% | 278.64% | 255.87% |
| Total Finance Division Other Current Liabilities | -8.66% | -36.90% | 569.31% | 88.04% | 243.65% |
| Total Other Current Liabilities | -8.66% | -36.90% | 569.31% | 88.04% | 243.65% |
| Total Current Liabilities | 1.46% | 7.47% | 17.76% | 13.44% | 30.71% |
|
|
|||||
| Total Current Liabilities | 1.46% | 7.47% | 17.76% | 13.44% | 30.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 35.41% | 59.15% | -16.82% | -33.75% | -36.66% |
| Capital Leases | -47.52% | -41.89% | -71.96% | -62.44% | -55.27% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 350.88% | 385.96% | 189.33% |
| Total Liabilities | -0.77% | 4.36% | -13.90% | -29.75% | -22.52% |
|
|
|||||
| Common Stock & APIC | -2.80% | 6.25% | 8.25% | 27.93% | 26.38% |
| Retained Earnings | -0.63% | -7.66% | -13.23% | -19.28% | -22.26% |
| Treasury Stock & Other | 5.17% | -0.57% | 9.16% | 10.91% | 8.14% |
| Total Common Equity | -30.64% | -21.11% | -8.15% | 2,286.53% | 366.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.64% | -21.11% | -8.15% | 2,286.53% | 366.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 936.41% | -67.07% | -889.82% | -3,882.11% | -576.72% |
| Total Equity | 6.27% | -42.24% | -11.94% | 2,233.05% | 331.65% |
|
|
|||||